As of 2024-10-03, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (9.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.30 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -272.6%.
The range of the Relative Valuation is (3.25) - (13.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.1x - 26.5x | 15.3x |
| Forward P/E multiples | 5.1x - 21.7x | 13.4x |
| Fair Price | (3.25) - (13.83) | (9.15) |
| Upside | -161.3% - -361.0% | -272.6% |
| Date | P/E |
| 2024-10-02 | -8.32 |
| 2024-10-01 | -8.30 |
| 2024-09-30 | -8.46 |
| 2024-09-27 | -8.63 |
| 2024-09-26 | -8.43 |
| 2024-09-25 | -8.47 |
| 2024-09-24 | -8.86 |
| 2024-09-23 | -8.75 |
| 2024-09-20 | -9.24 |
| 2024-09-19 | -9.48 |
| 2024-09-18 | -9.21 |
| 2024-09-17 | -9.07 |
| 2024-09-16 | -9.27 |
| 2024-09-13 | -9.46 |
| 2024-09-12 | -9.71 |
| 2024-09-11 | -9.71 |
| 2024-09-10 | -9.30 |
| 2024-09-09 | -9.27 |
| 2024-09-06 | -9.62 |
| 2024-09-05 | -9.92 |
| 2024-09-04 | -9.92 |
| 2024-09-03 | -9.08 |
| 2024-08-30 | -9.03 |
| 2024-08-29 | -8.43 |
| 2024-08-28 | -8.24 |
| 2024-08-27 | -8.43 |
| 2024-08-26 | -8.54 |
| 2024-08-23 | -8.74 |
| 2024-08-22 | -8.21 |
| 2024-08-21 | -8.41 |
| 2024-08-20 | -8.44 |
| 2024-08-19 | -8.46 |
| 2024-08-16 | -7.95 |
| 2024-08-15 | -8.24 |
| 2024-08-14 | -7.36 |
| 2024-08-13 | -7.39 |
| 2024-08-12 | -7.45 |
| 2024-08-09 | -8.00 |
| 2024-08-08 | -6.57 |
| 2024-08-07 | -5.11 |
| 2024-08-06 | -5.40 |
| 2024-08-05 | -5.06 |
| 2024-08-02 | -5.51 |
| 2024-08-01 | -5.82 |
| 2024-07-31 | -6.18 |
| 2024-07-30 | -6.20 |
| 2024-07-29 | -6.18 |
| 2024-07-26 | -6.51 |
| 2024-07-25 | -6.42 |
| 2024-07-24 | -6.13 |